| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/09/2008 | US7423114 GD2 ligands |
| 09/09/2008 | US7423058 Inhibitors of hepatitis C virus NS3 protease |
| 09/09/2008 | US7423024 Recombinant human alpha-fetoprotein as an immunosuppressive agent |
| 09/09/2008 | US7423023 Enhancement of immune response using targeting molecules |
| 09/09/2008 | US7423022 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 09/09/2008 | US7423021 Peptidic thrombin inhibitors |
| 09/09/2008 | US7423020 Therapy for behavior disorders; quantitative analysis; measuring binding |
| 09/09/2008 | US7423019 Chimeric glucagon-like peptide for prevention and treatment of pancreatic disorders |
| 09/09/2008 | US7423018 Using motor proteins to identify agents for prevention and treatment of cell proliferative and autoimmune disorders; RNA interference and gene expression inhibition; ribozymes |
| 09/09/2008 | US7423017 Method for treating cartilage disorders |
| 09/09/2008 | US7423016 Genetic engineering; inducting immunology response |
| 09/09/2008 | US7423014 Insulin conjugates for treating diabetes mellitus |
| 09/09/2008 | US7423012 Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors |
| 09/09/2008 | US7423011 Treating autoimmune diseases such as multiple sclerosis with CXCR4 antagonist such as peptides having of stromal cell derived factor one (SDF-1) sequences |
| 09/09/2008 | US7423009 Method for treatment of kidney diseases |
| 09/09/2008 | US7423007 Cxcr4 antagonist and use thereof |
| 09/09/2008 | US7422896 Compositions for DNA mediated gene silencing |
| 09/09/2008 | US7422890 Polynucleotide that encodes a polypeptide having activity as a phospholipase A2 inhibitor; especially obtained from the liver of a species of Python |
| 09/09/2008 | US7422886 Human Phosphoinositide I3 Kinase p110 Delta which interacts with p85, has a broad phosphinositide specificity and is sensitive to the same kinase inhibitors as PI3 Kinase p110A; selectively expressed in leucocytes; enhanced expression in most melanomas |
| 09/09/2008 | US7422883 Map kinase integrin-binding domain |
| 09/09/2008 | US7422878 Process for microbial production of ubiquinone-10 using Rhodobacter |
| 09/09/2008 | US7422877 Activatable recombinant neurotoxins |
| 09/09/2008 | US7422867 Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein |
| 09/09/2008 | US7422863 Molting hormone receptor and method for screening ligand to the receptor |
| 09/09/2008 | US7422849 Hybridizing sample with a nucleic acid molecule to a transcript of gene wherein said transcript is RNA or cDNA; determining hybridization as a determination of expression of gene |
| 09/09/2008 | US7422753 treating obsessions and compulsions, in particular trichotillomania, by local administration of Clostridial toxin; low dose, intramuscular administration of botulinum toxin |
| 09/09/2008 | US7422749 Isolated polypeptide, encoded by nucleic acid sequence, a vector from Staphylococcus; use for activators or inhibitors in therapy, antigen for vaccination, antibodies; antibacterial agent treating Staphylococcus infections; biodrugs |
| 09/09/2008 | US7422745 Methods of treating cancer with vαβ3-specific antibodies |
| 09/09/2008 | US7422744 Integrin mediated diseases like angiogenesis or restenosis; Vitaxin (a humanized monoclonal) antibody and a LM609 grafted antibody exhibiting selective binding affinity to alpha v beta 3 |
| 09/09/2008 | US7422743 Using DCRS5 (SEQ ID NOs: 1 or 2) or p19 (SEQ ID NOs: 5 or 6) cytokine receptors agonist or antagonist to treat rheumatoid arthritis, asthma, allergies, chronic obstructive pulmonary disorder, interstitial lung disorder, inflammatory bowel disorder, inflammatory skin disorder |
| 09/09/2008 | US7422740 Capable of inhibiting the cell division cycle in a target cell; for therapy of proliferative cell disorders and intracellular pathogens |
| 09/09/2008 | US7422739 Anti-CD20 antibodies |
| 09/09/2008 | US7422738 Combined cancer treatment methods using antibodies to aminophospholipids |
| 09/09/2008 | US7422733 Antiinflammatory agents; anticancer agents; antidiabetic agents |
| 09/09/2008 | CA2546625C Glycopeptide antibiotic derivatives |
| 09/09/2008 | CA2362769C Microcapsules for sustained release of drugs |
| 09/09/2008 | CA2323086C Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/09/2008 | CA2252163C D-proline derivatives |
| 09/09/2008 | CA2144855C Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 09/09/2008 | CA2133644C Process for making vancomycin |
| 09/04/2008 | WO2008106694A2 Systems, methods and compositions for optical stimulation of target cells |
| 09/04/2008 | WO2008106625A2 Porous composite biomaterials and related methods |
| 09/04/2008 | WO2008106491A2 Peptides that interact with topoisomerase i and methods thereof |
| 09/04/2008 | WO2008106478A1 Compositions and methods for modification of target cells and to their uses thereof |
| 09/04/2008 | WO2008106130A2 Tertiary amine substituted peptides useful as inhibitors of hcv replication |
| 09/04/2008 | WO2008106074A2 Methods of treating infection |
| 09/04/2008 | WO2008105917A2 Polyvalent inhibitors of pathogens |
| 09/04/2008 | WO2008105911A2 Crystallized oxalate decarboxylase and methods of use |
| 09/04/2008 | WO2008105835A2 Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity |
| 09/04/2008 | WO2008105826A2 Compositions compromising lysostaphin variants and methods of using the same |
| 09/04/2008 | WO2008105759A1 Methods for synthesis of modified peptides |
| 09/04/2008 | WO2008105514A1 Multibranched polyoxyalkylene derivative |
| 09/04/2008 | WO2008105507A1 Therapeutic agent for spinal cord injury |
| 09/04/2008 | WO2008105462A1 Method for activation of helper t cell and composition for use in the method |
| 09/04/2008 | WO2008105454A1 Cell capable of expressing lacritin at high level |
| 09/04/2008 | WO2008105441A1 Poly(amino acid) compound having inhibitory activity on absorption of phosphorus and phosphorus absorption inhibitor |
| 09/04/2008 | WO2008105113A1 Oral disinfectant, food additive comprising the disinfectant |
| 09/04/2008 | WO2008105088A1 Agent for treating spinal cord injury |
| 09/04/2008 | WO2008104867A1 High calorie and easily digestible food |
| 09/04/2008 | WO2008104747A1 Use of vegf in the treatment of retarded fetal growth in pregnancy |
| 09/04/2008 | WO2008104620A1 Use of matrix metalloproteinase-10 (mmp-10) for thrombolytic treatments |
| 09/04/2008 | WO2008104203A2 18f fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precursers |
| 09/04/2008 | WO2008104200A1 Use of apyrase for the treatment of a pathology resulting from endotoxin activity |
| 09/04/2008 | WO2008104199A1 Use of ecto-phosphatases for the treatment of (acute) myocardial infarction |
| 09/04/2008 | WO2008104090A1 Template-fixed peptidomimetics |
| 09/04/2008 | WO2008104062A2 Selective release of pro-apoptotic bcl-2 family members and their contribution to the bystander effect |
| 09/04/2008 | WO2008087189A3 Peptides for use in the treatment of obesity |
| 09/04/2008 | WO2008087188A3 Peptides for use in the treatment of obesity |
| 09/04/2008 | WO2008079973A3 Egfr binding peptides and uses thereof |
| 09/04/2008 | WO2008071418A3 Use of the endoglycosidase endos for treating immunoglobulin g mediated diseases |
| 09/04/2008 | WO2008061048A3 Methods and compositions for diagnosing and treating prostate cancer |
| 09/04/2008 | WO2008060622A3 Improved methods and compositions for wound healing |
| 09/04/2008 | WO2008055310A8 Process for the preparation of angiogenin |
| 09/04/2008 | WO2008039941A3 Scgb3a2 as a growth factor and anti-apoptotic agent |
| 09/04/2008 | WO2008013935A3 Tyrosine phosphorylation sites |
| 09/04/2008 | WO2008000513A3 Peptide compounds for the treatment of hyperexcitability disorders and diseases associated with ion channel dysfunction |
| 09/04/2008 | WO2007144195A3 Pharmaceutical composition with synergistic anticonvulsant effect |
| 09/04/2008 | WO2007139826A3 Method for elevating prolactin in mammals |
| 09/04/2008 | WO2007134813A3 Use of desmodus salivary plasminogen activator (dspa) for treating venous thromboembolism |
| 09/04/2008 | WO2007130962A3 Diagnosis of cardiovascular disease |
| 09/04/2008 | WO2007084460A8 Pharmaceutical compositions with enhanced stability |
| 09/04/2008 | WO2007044396A3 Fibronectin polypeptides and methods of use |
| 09/04/2008 | WO2006047535A3 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 09/04/2008 | WO2005025489A3 Therapeutic use of g53135-05(fgf-20) in radiation protection |
| 09/04/2008 | WO1997013786A9 Streptoccal inhibitor of complement-mediated lysis, protein sic |
| 09/04/2008 | US20080214786 Modified Powder, Fluid Composition Containing Said Modified Powder, Formed Article, and Method For Producing Modified Powder |
| 09/04/2008 | US20080214785 Heterodimeric receptor complex which antagonizes IL-10-related T cell-derived inducible factor for use in diagnosis, treatment and prevention of spleen associated cell proliferative disorders |
| 09/04/2008 | US20080214781 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 09/04/2008 | US20080214648 Hiv Prodrugs Cleavable by Cd26 |
| 09/04/2008 | US20080214640 3'-{[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid or a salt; treatment of thrombocytopenia; may be coadministered with a colony stimulating factor, cytokine, chemokine, or an interleukin or cytokine receptor agonist or antagonist |
| 09/04/2008 | US20080214517 Modulation of the Expression of Estrogen Receptors for the Prevention or Treatment of Heart Disease |
| 09/04/2008 | US20080214487 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 09/04/2008 | US20080214478 Small Peptides And Methods For Inhibiting The Infiltration Of Eosinophils Into Airways |
| 09/04/2008 | US20080214477 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting t-cell migration; immunotherapy |
| 09/04/2008 | US20080214476 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting mucous release into airways of patients; immunotherapy |
| 09/04/2008 | US20080214475 Small Peptides And Methods For Inhibiting The Mucous Release Into Airways |
| 09/04/2008 | US20080214474 Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease |
| 09/04/2008 | US20080214473 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; treatment and prevention of respiratory system disorders; antiinflammatory agents; immunotherapy |
| 09/04/2008 | US20080214472 Small Peptides And Methods For Treatment Of Arthritis |
| 09/04/2008 | US20080214471 Method for inhibition of viral infection |